問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Fu Jen Catholic University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2024-08-01 - 2027-12-31
Condition/Disease
Test Drug
Participate Sites5Sites
Recruiting5Sites
2024-10-30 - 2026-12-31
Participate Sites6Sites
Recruiting6Sites
2022-04-01 - 2025-12-31
2024-02-26 - 2026-07-28
Participate Sites8Sites
Not yet recruiting1Sites
Recruiting7Sites
2023-02-01 - 2028-01-31
Participate Sites10Sites
Not yet recruiting6Sites
Recruiting4Sites
2023-12-01 - 2026-12-31
xxxxxx
Participate Sites3Sites
Recruiting3Sites
2024-07-01 - 2027-12-31
chronic kidney disease
placebo ‧ BI 690517 Empagliflozin
Participate Sites23Sites
Recruiting23Sites
2020-12-01 - 2022-10-25
Type 2 Diabetes Mellitus (T2DM)
TTP273 Table
Participate Sites4Sites
全部
